| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/06/2005 | CA2528281A1 Methods for identifying agents, which regulate cytokines |
| 01/06/2005 | CA2528067A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | CA2527689A1 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | CA2526284A1 Binding molecules for the treatment of myeloid cell malignancies |
| 01/06/2005 | CA2526085A1 Treatment with anti-vegf antibodies |
| 01/06/2005 | CA2526080A1 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 01/06/2005 | CA2525251A1 Cd20-specific antibodies and methods of employing same |
| 01/05/2005 | EP1493825A2 Method for producing nucleic acid ligands |
| 01/05/2005 | EP1493751A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 01/05/2005 | EP1493750A2 HCV regulated proteins |
| 01/05/2005 | EP1493749A1 Novel HCV core + 1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
| 01/05/2005 | EP1493034A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2005 | EP1493033A2 Sc6 for diagnosis of hypoxia related conditions |
| 01/05/2005 | EP1492882A1 Methods and reagents for assaying protein kinase activity |
| 01/05/2005 | EP1492870A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 01/05/2005 | EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/05/2005 | EP1492819A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 01/05/2005 | EP1492818A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492566A2 Binding agents and their use in targeting tumor cells |
| 01/05/2005 | EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
| 01/05/2005 | EP1397386A4 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 01/05/2005 | EP0837930B1 A TRP-226 MUTANT HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/05/2005 | EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 01/05/2005 | EP0699078B1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561395A Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560081A Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof |
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1560079A Deep-processing method for animal blood |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183159C Osteoclast forming nihibitory factor monoclonal anti-body, its use and kit |
| 01/05/2005 | CN1183155C Peptide useful as ligand |
| 01/04/2005 | US6838554 Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes |
| 01/04/2005 | US6838548 Artiodactyl epimorphine |
| 01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
| 01/04/2005 | US6838290 Detecting modulators of interleukin activity; obtain modulator, incubate with preferential cells, monitor interleukin response |
| 01/04/2005 | US6838282 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy |
| 01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains |
| 01/04/2005 | US6838264 Antigenic peptide for inducing the formation of antibodies |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838254 Preparing catalytic antibodies for use as diagnostic tools in disease detection |
| 01/04/2005 | US6838250 Performing competitive immunoassay for detecting C-reactive protein; obtain fliud sample, incubate with antibody, detect signal, corelate signal with c-reactive protein in sample |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 01/04/2005 | US6838085 DNA immunization against Chlamydia infection |
| 01/04/2005 | CA2470262A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/04/2005 | CA2434685A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2434668A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 12/30/2004 | US20040268426 P2Y4 receptor transgenic and knockout non-human mammals |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/30/2004 | US20040266993 Therapeutic fusion protein comprising variable region complementarity determining regions which exhibit similar or better binding characteristics as monoclonal antibodies; immunotherapy and treatment of metabolic disorders |
| 12/30/2004 | US20040266990 Cd109 nucleic acid molecules polypeptides and methods of use |
| 12/30/2004 | US20040266691 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide |
| 12/30/2004 | US20040265981 A cDna clone; culturing liver cell in coditioning media |
| 12/30/2004 | US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265964 Using aromatic carboxylic acid such as hydrocinnamic acid as an inducer of preferential gene expression in transgenic rodent ovaries comprising vector coding cytomegalo viral promoter; bioreactors and heterologous gene expression |
| 12/30/2004 | US20040265960 Antibodies against human IL-21 receptor and uses therefor |
| 12/30/2004 | US20040265957 Monoclonal antibody inhibitor of GM-CSF, IL-3, IL-5 and other cytokines, and uses thereof |
| 12/30/2004 | US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 12/30/2004 | US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression |
| 12/30/2004 | US20040265937 Diagnosing malignacy and respiratory system disorder via concentration of extracellular matrix protein; immunodiagnostics |
| 12/30/2004 | US20040265935 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 12/30/2004 | US20040265932 Detecting mRNA which translates into mammaglobin and mucin-like proteins, then detecting cDNA; isolated from Bacillus substilis; solid phase synthesis |
| 12/30/2004 | US20040265930 Monoclonal antibody 7H11 reactive with human cancer |
| 12/30/2004 | US20040265929 Detecting huntingtin interactin protein (HIP1) antibodies; for diagnosis/treatment of colon/prostate cancer; drug screening; kits |
| 12/30/2004 | US20040265920 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay |
| 12/30/2004 | US20040265919 Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265901 Compositions and methods for generating antigen-binding units |
| 12/30/2004 | US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265887 predicting a clinical response to treatment with a chemotherapeutic agent by determining the activity of a gene encoding a DNA repair enzyme |
| 12/30/2004 | US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265857 Cloning gene or fragment thereof via hybridization probe; solid phase synthesis; plasmids; for treating mycosis |
| 12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
| 12/30/2004 | US20040265839 Gene knockout; gene overexpression; liposomes; fusion proteins; immunoglobulins; FC fragments; glutathione S-transferase (GST) polypeptides |
| 12/30/2004 | US20040265825 Methods and compositions for diagnosing and treating a subject having depression |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265804 Method for identifying metastatic tumor cells |